Study reveals pathogenic factor that triggers prion and neurodegenerative diseases

Transmissible spongiform encephalopathy or prion disease is triggered by the conversion from cellular prion protein to pathogenic prion protein. Notably, C-transmembrane form of prion protein and cytosolic prion protein can result in neurodegenerative diseases in cases of error location,aggregation tendency, failure of signal peptides, body stress or incomplete removal of topologic prion protein.

Zhiqi Song and coworkers from China Agricultural University, China introduce two types of disease-associated prion proteins, the cytosolic form and the transmembrane form, during biosynthesis through the endoplasmic reticulum quality-control system, and propose an effective model and testing method for cytosolic forms of prion protein. Their studies, published in the Neural Regeneration Research (Vol. 8, No. 30, 2013), addressing the molecular mechanisms show that the pathogenic factor for prion disease is not limited to the prion protein, but also includes the complex intracellular environment, error location or incomplete removal of topologic prion protein.

Article: " Metabolism of minor isoforms of prion proteins: cytosolic prion protein and transmembrane prion protein," by Zhiqi Song, Deming Zhao, Lifeng Yang (State Key Laboratory for Agrobiotechnology, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China)

Song ZQ, Zhao DM, Yang LF. Metabolism of minor isoforms of prion proteins: cytosolic prion protein and transmembrane prion protein. Neural Regen Res. 2013;8(30):2868-2878.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How innovation in dried blood spot testing is transforming neurological disease monitoring